|
| |
| | | 00669 | | 28.07.2003 | | GlaxoSmithKline AG | | | | | | | 29.07.2023 | | | | | | 08.08. | | | | 08.08. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Poliorix | Injektionslösung | Solution injectable () + (Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 U, Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 U, Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 U) | J07BF03 | |
|
|
|
